1. The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition
   Gilda Varricchi et al, 2019, International Journal of Molecular Sciences CrossRef
2. ICAM2 is related to good prognosis in dendritic cell immunotherapy for cancer
   Saulo FM da Silva et al, 2024, Immunotherapy CrossRef
3. Immunohistochemical expression of interleukin-17 and hormonal receptors in benign and malignant breast lesions
   Eman Taha Ali et al, 2020, BMC Research Notes CrossRef
4. Dynamic Immune Function Changes Before and After the First Radioactive Iodine Therapy After Total Resection of Differentiated Thyroid Carcinoma
   Zhi-Yong Shi et al, 2022, Frontiers in Immunology CrossRef
5. Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer
   Peng Lin et al, 2019, Aging CrossRef
6. Mir-124 Attenuates STAT3-Mediated TH17 Differentiation in Colitis-Driven Colon Cancer
   Shiyong Lin et al, 2020, Frontiers in Oncology CrossRef
7. Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer Immunotherapy
   Irene Olivera et al, 2023, Clinical Cancer Research CrossRef
8. Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells
   Ronald Anderson et al, 2019, Frontiers in Immunology CrossRef
9. Intermittent hypoxia induces tumor immune escape in murine S180 solid tumors via the upregulation of TGF-β1 in mice
   Lijuan Ma et al, 2021, Sleep and Breathing CrossRef
10. Systems Biology Approaches to Investigate Genetic and Epigenetic Molecular Progression Mechanisms for Identifying Gene Expression Signatures in Papillary Thyroid Cancer
    Shan-Ju Yeh et al, 2019, International Journal of Molecular Sciences CrossRef
11. RET-mediated modulation of tumor microenvironment and immune response in multiple endocrine neoplasia type 2 (MEN2)
    Maria Domenica Castellone et al, 2018, Endocrine-Related Cancer CrossRef
12. Interleukin‑17 promotes the development of cisplatin resistance in colorectal cancer
    Guolong Sui et al, 2018, Oncology Letters CrossRef
13. Polymorphisms at the IL17A and IL17RA Genes are Associated with Prognosis of Papillary Thyroid Carcinoma
    Bruna Cristina Bertol et al, 2022, Archives of Medical Research CrossRef
14. Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice
    Chuang Xi et al, 2020, Frontiers in Immunology CrossRef
15. RORγt may Influence the Microenvironment of Thyroid Cancer Predicting Favorable Prognosis
    Lucas Leite Cunha et al, 2020, Scientific Reports CrossRef
16. IL-17 A correlates with disease progression in papillary thyroid carcinoma
    Sohini Banerjee et al, 2023, Diagnostic Pathology CrossRef
17. The Role of Inflammation-Associated Factors in Head and Neck Squamous Cell Carcinoma
    Kang Li et al, 2023, Journal of Inflammation Research CrossRef
18. The IL-17 family in diseases: from bench to bedside
    Longjie Huangfu et al, 2023, Signal Transduction and Targeted Therapy CrossRef
19. Effects of iodine-131 radiotherapy on Th17/Tc17 and Treg/Th17 cells of patients with differentiated thyroid carcinoma
    Lixia Zhang et al, 2017, Experimental and Therapeutic Medicine CrossRef
20. Analysis of the value and safety of thyroid-stimulating hormone in the clinical efficacy of patients with thyroid cancer
    Jian-Jing Liang et al, 2023, World Journal of Clinical Cases CrossRef